Display options
Cite
Bužga M, Holéczy P, Švagera Z, et al. Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study. Wideochir Inne Tech Maloinwazyjne. 2015;10(3):398-405doi: 10.5114/wiitm.2015.54103.
Bužga, M., Holéczy, P., Švagera, Z., & Zonča, P. (2015). Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 10(3), 398-405. https://doi.org/10.5114/wiitm.2015.54103
Bužga, Marek, et al. "Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study." Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques vol. 10,3 (2015): 398-405. doi: https://doi.org/10.5114/wiitm.2015.54103
Bužga M, Holéczy P, Švagera Z, Zonča P. Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study. Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):398-405. doi: 10.5114/wiitm.2015.54103. Epub 2015 Sep 14. PMID: 26649086; PMCID: PMC4653266.
Copy Download .nbib Format: NLM
Share it on

Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):398-405. doi: 10.5114/wiitm.2015.54103. Epub 2015 Sep 14.

Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study.

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques

Marek Bužga, Pavol Holéczy, Zdeněk Švagera, Pavel Zonča

Affiliations

  1. Department of Physiology and Pathophysiology, University of Ostrava, Ostrava, Czech Republic.
  2. Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  3. Department of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.

PMID: 26649086 PMCID: PMC4653266 DOI: 10.5114/wiitm.2015.54103

Abstract

INTRODUCTION: Laparoscopic greater curvature plication (LGCP) is a novel restrictive technique that reduces gastric volume by plication of the greater curvature. The advantage of LGCP is its reversibility in comparison to laparoscopic sleeve gastrectomy. Nowadays, the long-term LGCP efficacy, safety and metabolic effect are being investigated.

AIM: To assess body composition, clinical complications and metabolic changes in obese patients 6 and 12 months after laparoscopic greater curvature plication.

MATERIAL AND METHODS: A total of 70 subjects underwent LGCP; 52 of them (33 women and 19 men) completed 1-year follow-up study. Anthropometry and biochemical parameters (glucose, glycated haemoglobin, lipids, ghrelin, leptin, adiponectin and fibroblast growth factor 21 [FGF-21]) were assessed before and 3, 6, and 12 months after surgery.

RESULTS: All study participants exhibited statistically significant weight loss at both 6 and 12 months following the LGCP compared to baseline, with significant reductions in body composition - body weight, body mass index, percentage excess weight loss (%EWL), and percentage excess BMI loss (%EBL) (p ≤ 0.001). Moreover, significant lowering of glucose and glycated haemoglobin, triacylglycerols and leptin was observed 12 months after LGCP. On the other hand, plasma concentrations of ghrelin, adiponectin and LDL cholesterol increased significantly. Total cholesterol, LDL cholesterol and FGF-21 levels did not change significantly.

CONCLUSIONS: Laparoscopic greater curvature plication appears to be a procedure with good restriction results, which might be mediated through alteration in incretin metabolism. Technical aspects and standardization of the procedure still remain to be worked out.

Keywords: fibroblast growth factor 21; gastric plication; ghrelin; metabolic effect; weight loss

References

  1. Metabolism. 2011 Feb;60(2):306-11 - PubMed
  2. Surg Obes Relat Dis. 2015 Jan-Feb;11(1):125-30 - PubMed
  3. Ann Surg. 2006 Nov;244(5):715-22 - PubMed
  4. Clin Endocrinol (Oxf). 2009 Sep;71(3):369-75 - PubMed
  5. Wideochir Inne Tech Maloinwazyjne. 2012 Dec;7(4):251-9 - PubMed
  6. Obes Surg. 2014 Jan;24(1):42-55 - PubMed
  7. Obes Surg. 2012 Sep;22(9):1496-506 - PubMed
  8. Vnitr Lek. 2010 Oct;56(10):1019-27 - PubMed
  9. J Clin Endocrinol Metab. 2012 Jun;97(6):2143-50 - PubMed
  10. Obes Surg. 2014 Jun;24(6):909-15 - PubMed
  11. BMC Public Health. 2012 Jun 18;12:439 - PubMed
  12. Wideochir Inne Tech Maloinwazyjne. 2013 Mar;8(1):22-8 - PubMed
  13. Wideochir Inne Tech Maloinwazyjne. 2012 Aug;7(3):188-92 - PubMed
  14. Surg Obes Relat Dis. 2011 Sep-Oct;7(5):561-8 - PubMed
  15. Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1226-32 - PubMed
  16. Eur J Endocrinol. 2012 Sep;167(3):301-9 - PubMed
  17. JAMA. 2004 Oct 13;292(14):1724-37 - PubMed
  18. Obes Surg. 2010 Jun;20(6):776-90 - PubMed
  19. Obes Surg. 2010 Jul;20(7):913-8 - PubMed
  20. Med Clin North Am. 2007 Nov;91(6):1255-71, xi - PubMed
  21. Wideochir Inne Tech Maloinwazyjne. 2014 Dec;9(4):608-12 - PubMed
  22. Arq Bras Cir Dig. 2013;26 Suppl 1:8-12 - PubMed
  23. J Nutr. 2004 Feb;134(2):295-8 - PubMed
  24. Obes Surg. 2011 Nov;21(11):1657-63 - PubMed
  25. Obes Surg. 2014 May;24(5):718-26 - PubMed
  26. Obesity (Silver Spring). 2013 Jul;21(7):1335-42 - PubMed
  27. Am J Med. 2009 Mar;122(3):248-256.e5 - PubMed
  28. Surg Endosc. 2013 Aug;27(8):2768-74 - PubMed
  29. Arch Surg. 2011 Feb;146(2):143-8 - PubMed
  30. Surg Endosc. 2010 May;24(5):1005-10 - PubMed

Publication Types